These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

415 related articles for article (PubMed ID: 28834075)

  • 41. Improving glycaemic control in type 2 diabetes: Stimulate insulin secretion or provide beta-cell rest?
    van Raalte DH; Verchere CB
    Diabetes Obes Metab; 2017 Sep; 19(9):1205-1213. PubMed ID: 28295962
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Premixed insulin regimens in type 2 diabetes: pros.
    Maiorino MI; Bellastella G; Esposito K; Giugliano D
    Endocrine; 2017 Jan; 55(1):45-50. PubMed ID: 27003435
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A pilot study of factors associated with glycaemic control in adults with Type 1 diabetes mellitus on insulin pump therapy.
    Wen W; Frampton R; Wright K; Fattore S; Shadbolt B; Perampalam S
    Diabet Med; 2016 Feb; 33(2):231-4. PubMed ID: 26484625
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Long-term effects on glycaemic control and β-cell preservation of early intensive treatment in patients with newly diagnosed type 2 diabetes: A multicentre randomized trial.
    Chon S; Rhee SY; Ahn KJ; Baik SH; Park Y; Nam MS; Lee KW; Yoo SJ; Koh G; Lee DH; Kim YS; Woo JT;
    Diabetes Obes Metab; 2018 May; 20(5):1121-1130. PubMed ID: 29272062
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Appropriateness of action prompts for hypoglycaemia and hyperglycaemia in type 2 diabetes self-management apps.
    Lum E; Jimenez G; Huang Z; Thai L; Car J
    Diabetes Metab Res Rev; 2020 Feb; 36(2):e3235. PubMed ID: 31721421
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The effect of an education programme (MEDIAS 2 BSC) of non-intensive insulin treatment regimens for people with Type 2 diabetes: a randomized, multi-centre trial.
    Hermanns N; Ehrmann D; Schall S; Maier B; Haak T; Kulzer B
    Diabet Med; 2017 Aug; 34(8):1084-1091. PubMed ID: 28257159
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Evaluation of the Clinical and Economic Burden of Poor Glycemic Control Associated with Therapeutic Inertia in Patients with Type 2 Diabetes in the United States.
    Ali SN; Dang-Tan T; Valentine WJ; Hansen BB
    Adv Ther; 2020 Feb; 37(2):869-882. PubMed ID: 31925649
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Under-treatment of type 2 diabetes: Causes and outcomes of clinical inertia.
    Bailey CJ
    Int J Clin Pract; 2016 Dec; 70(12):988-995. PubMed ID: 28032429
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Impact of Current and Emerging Glucose-Lowering Drugs on Body Weight in Type 2 Diabetes.
    Lau DC; Teoh H
    Can J Diabetes; 2015 Dec; 39 Suppl 5():S148-54. PubMed ID: 26654858
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Factors associated with clinical inertia in type 2 diabetes mellitus patients treated with metformin monotherapy.
    Kartoun U; Iglay K; Shankar RR; Beam A; Radican L; Chatterjee A; Pai JK; Shaw S
    Curr Med Res Opin; 2019 Dec; 35(12):2063-2070. PubMed ID: 31337263
    [No Abstract]   [Full Text] [Related]  

  • 51. Efficacy and safety of pioglitazone added to alogliptin in Japanese patients with type 2 diabetes mellitus: a multicentre, randomized, double-blind, parallel-group, comparative study.
    Kaku K; Katou M; Igeta M; Ohira T; Sano H
    Diabetes Obes Metab; 2015 Dec; 17(12):1198-201. PubMed ID: 26277887
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Lixisenatide as add-on to oral anti-diabetic therapy: an effective treatment for glycaemic control with body weight benefits in type 2 diabetes.
    Raccah D; Gourdy P; Sagnard L; Ceriello A
    Diabetes Metab Res Rev; 2014 Nov; 30(8):742-8. PubMed ID: 24687427
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Sustained efficacy of insulin pump therapy compared with multiple daily injections in type 2 diabetes: 12-month data from the OpT2mise randomized trial.
    Aronson R; Reznik Y; Conget I; Castañeda JA; Runzis S; Lee SW; Cohen O;
    Diabetes Obes Metab; 2016 May; 18(5):500-7. PubMed ID: 26854123
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Slow Titration and Delayed Intensification of Basal Insulin Among Patients with Type 2 Diabetes.
    Mocarski M; Yeaw J; Divino V; DeKoven M; Guerrero G; Langer J; Thorsted BL
    J Manag Care Spec Pharm; 2018 Apr; 24(4):390-400. PubMed ID: 29406841
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Efficacy and tolerability of the new autoinjected suspension of exenatide once weekly versus exenatide twice daily in patients with type 2 diabetes.
    Wysham CH; Rosenstock J; Vetter ML; Dong F; Öhman P; Iqbal N
    Diabetes Obes Metab; 2018 Jan; 20(1):165-172. PubMed ID: 28685973
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Mobile phone applications and self-management of diabetes: A systematic review with meta-analysis, meta-regression of 21 randomized trials and GRADE.
    Hou C; Xu Q; Diao S; Hewitt J; Li J; Carter B
    Diabetes Obes Metab; 2018 Aug; 20(8):2009-2013. PubMed ID: 29582538
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The co-formulation of insulin degludec and insulin aspart lowers fasting plasma glucose and rates of confirmed and nocturnal hypoglycaemia, independent of baseline glycated haemoglobin levels, disease duration or body mass index: A pooled meta-analysis of phase III studies in patients with type 2 diabetes.
    Haluzík M; Fulcher G; Pieber TR; Bardtrum L; Tutkunkardas D; Rodbard HW
    Diabetes Obes Metab; 2018 Jul; 20(7):1585-1592. PubMed ID: 29451706
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Comparative effectiveness and safety of different basal insulins in a real-world setting.
    Ji L; Zhang P; Zhu D; Lu J; Guo X; Wu Y; Li X; Ji J; Jia W; Yang W; Zou D; Zhou Z; Gao Y; Garg SK; Pan C; Weng J; Paul SK;
    Diabetes Obes Metab; 2017 Aug; 19(8):1116-1126. PubMed ID: 28230322
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A Greek registry of current type 2 diabetes management, aiming to determine core clinical approaches, patterns and strategies.
    Liatis S; Iraklianou S; Kazakos K; Mastorakos G; Milios K; Mouslech Z; Noutsou M; Pagkalos E; Sampanis C;
    BMC Endocr Disord; 2019 Apr; 19(1):39. PubMed ID: 31023374
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Intensive glycemic control in younger and older U.S. adults with type 2 diabetes.
    Casagrande S; Cowie CC; Fradkin JE
    J Diabetes Complications; 2017 Aug; 31(8):1299-1304. PubMed ID: 28571934
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.